What GenAI Means for Life Sciences IT Leaders...

A growing share of pharmaceutical innovation is now constrained not by scientific imagination, but by the infrastructure required to support AI at scale. In this episode of the AI in Business podcast, Thomas Fuchs, Chief AI Officer at Eli Lilly & Company, joins Matthew DeMello to ...  Show more

Boards are pushing CIOs to commit to AI strategies built on contracts written for an entirely different era of enterprise software. In this episode, John Belden, Chief of Research and Strategy at UpperEdge, breaks down the six dimensions of uncertainty CIOs now face when weighing ...  Show more

Artificial intelligence is the new electricity. The fifth industrial revolution. And companies that go all-in on AI are reaping the rewards. So how do you make that happen? That big question — how? — is explored by Nitin Mittal, Principal at Deloitte, one of the world’s largest p ...  Show more

Andrew McAfee, Principal Research Scientist at MIT and author of The Geek Way, explains how the OpenAI saga could impact future development of artificial intelligence. Mary Lou Gardner, Associate Partner for CPG, Retail and Logistics at Infosys Consulting, discusses retail earnin ...  Show more

Research advances over the past five years in artificial intelligence and machine learning have caused organizations of all kinds to look for ways to apply these powerful algorithms and techniques in their businesses. Eventually, AI could have the same impact that electricity had ...  Show more

Welcome to Talking Aerospace Today – a podcast for the aerospace and defense industry. A place that brings the promise of tomorrow’s technology to the ears of our listeners today.This series has covered many topics related to artificial intelligence and the A&D industry, from why ...  Show more